Literature DB >> 1883125

NIH conference. Systemic lupus erythematosus.

A D Steinberg, M F Gourley, D M Klinman, G C Tsokos, D E Scott, A M Krieg.   

Abstract

Although the cause of systemic lupus erythematosus remains unknown, pathogenic mechanisms are becoming clearer. Both genetic and environmental factors have been implicated in the induction and in the perpetuation of lupus. Implicated environmental triggers include ultraviolet light, chemicals (hydrazines, hair dyes, drugs), some foods, and possibly infectious agents. Lupus is mediated by the immune system. Patients have excess numbers of antibody-forming cells, including those that produce antibodies reactive with self-antigens. Patients also have an increased number of activated T cells, some of which help B cells to produce autoantibodies. A loss of tolerance is a critical immune abnormality in lupus; many of the activated helper T cells may result from a failure in normal tolerance mechanisms. A hematopoietic stem-cell defect could give rise to both B- and T-cell abnormalities. Such a stem-cell abnormality might lead to both a loss of self-tolerance and polyclonal B-cell activation. Antigen-driven, T-cell-dependent expansion of B-cell clones would then give rise to pathogenic autoantibodies, including anti-DNA. We believe that lupus is a syndrome: Patients differ regarding specific inciting factors and immune defects. Some patients have genetically conditioned abnormalities, similar to those found in mice with lupus; others have a combination of genetic and acquired defects. We hope that insights into pathogenesis lead to improved and more individualized therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883125     DOI: 10.7326/0003-4819-115-7-548

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

Review 2.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 3.  Review of the literature: integrating psychoneuroimmunology into pediatric chronic illness interventions.

Authors:  Jack H Nassau; Karen Tien; Gregory K Fritz
Journal:  J Pediatr Psychol       Date:  2007-09-10

4.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

5.  The human autoantigen MCP1 is required during early stages of DNA replication.

Authors:  E Bronze-da-Rocha; A Nóvoa; C Cunha; M do Carmo-Fonseca; N A Staines; C E Sunkel
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

6.  Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice.

Authors:  R Yung; D Powers; K Johnson; E Amento; D Carr; T Laing; J Yang; S Chang; N Hemati; B Richardson
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

7.  Hypersensitivity to molybdenum as a possible trigger of ANA-negative systemic lupus erythematosus.

Authors:  M Federmann; B Morell; G Graetz; M Wyss; P Elsner; R von Thiessen; B Wüthrich; D Grob
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

8.  Pathogenic mechanisms in systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

9.  Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study.

Authors:  C J Hardy; B P Palmer; K R Muir; A J Sutton; R J Powell
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

Review 10.  Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Jing Wang; Hai-Feng Pan; Dong-Qing Ye; Hong Su; Xiang-Pei Li
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.